VC

Vivo Capital Portfolio holdings

AUM $977M
This Quarter Return
+47.84%
1 Year Return
+209.68%
3 Year Return
+1,480.07%
5 Year Return
+2,591.98%
10 Year Return
–
AUM
$913M
AUM Growth
+$913M
Cap. Flow
+$115M
Cap. Flow %
12.62%
Top 10 Hldgs %
62.91%
Holding
56
New
8
Increased
8
Reduced
5
Closed
3

Top Buys

1
SLNO icon
Soleno Therapeutics
SLNO
$94.5M
2
GRCL
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$19.9M
3
RYZB
RayzeBio, Inc. Common Stock
RYZB
$14.1M
4
CMPS
Compass Pathways
CMPS
$11.9M
5
CRNX icon
Crinetics Pharmaceuticals
CRNX
$10.4M

Top Sells

1
VECT
VectivBio Holding AG Ordinary Shares
VECT
$39.4M
2
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
$35.9M
3
ASLN
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$4.27M
4
IMUX icon
Immunic
IMUX
$1.59M
5
CLNN icon
Clene
CLNN
$990K

Sector Composition

1 Healthcare 99.8%
2 Consumer Staples 0.15%
3 Materials 0.05%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
GTH
1
DELISTED
Genetron Holdings Limited ADS
GTH
$105M 11.46% 8,124,174 – –
SLNO icon
2
Soleno Therapeutics
SLNO
$3.6B
$94.5M 10.36% +3,203,093 New +$94.5M
HRMY icon
3
Harmony Biosciences
HRMY
$2.12B
$85.4M 9.36% 2,606,247 – –
VRNA
4
Verona Pharma
VRNA
$9.16B
$69.3M 7.59% 4,249,918 – –
AVDL
5
Avadel Pharmaceuticals
AVDL
$1.43B
$42.2M 4.62% 4,096,428 +266,851 +7% +$2.75M
TARS icon
6
Tarsus Pharmaceuticals
TARS
$2.47B
$40.2M 4.4% 2,262,200 – –
SVA
7
DELISTED
Sinovac Biotech, Ltd
SVA
$38.2M 4.18% 5,900,000 – –
GERN icon
8
Geron
GERN
$893M
$35M 3.84% 16,524,634 – –
TERN icon
9
Terns Pharmaceuticals
TERN
$609M
$33.5M 3.67% 6,657,992 – –
GRCL
10
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$31.3M 3.43% 10,881,144 +6,911,717 +174% +$19.9M
VRDN icon
11
Viridian Therapeutics
VRDN
$1.5B
$25.7M 2.82% 1,678,207 – –
OLMA icon
12
Olema Pharmaceuticals
OLMA
$375M
$23.1M 2.54% 1,873,704 +534,433 +40% +$6.6M
COGT icon
13
Cogent Biosciences
COGT
$1.69B
$21.9M 2.4% 2,244,941 – –
ALXO icon
14
ALX Oncology
ALXO
$62.7M
$20.3M 2.22% 4,220,048 – –
ACLX icon
15
Arcellx
ACLX
$3.85B
$18.1M 1.98% 503,565 +69,780 +16% +$2.5M
VTYX icon
16
Ventyx Biosciences
VTYX
$171M
$14.7M 1.61% 422,075 – –
RYZB
17
DELISTED
RayzeBio, Inc. Common Stock
RYZB
$14.1M 1.54% +633,576 New +$14.1M
ICVX
18
DELISTED
Icosavax, Inc. Common Stock
ICVX
$13.2M 1.45% 1,704,568 – –
ATXS icon
19
Astria Therapeutics
ATXS
$349M
$12.5M 1.37% 1,681,199 – –
VSTM icon
20
Verastem
VSTM
$569M
$12.5M 1.37% 1,538,461 – –
CMPS
21
Compass Pathways
CMPS
$424M
$11.9M 1.3% +1,608,000 New +$11.9M
ZLAB icon
22
Zai Lab
ZLAB
$3.68B
$11.1M 1.21% 454,606 +9,101 +2% +$221K
ALPN
23
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$10.5M 1.15% 914,913 – –
CRNX icon
24
Crinetics Pharmaceuticals
CRNX
$2.92B
$10.4M 1.14% +350,000 New +$10.4M
DYN icon
25
Dyne Therapeutics
DYN
$1.92B
$9.27M 1.02% 1,035,136 +457,494 +79% +$4.1M
1
2 3